pubmed-article:17400462 | rdf:type | pubmed:Citation | lld:pubmed |
pubmed-article:17400462 | lifeskim:mentions | umls-concept:C1467684 | lld:lifeskim |
pubmed-article:17400462 | lifeskim:mentions | umls-concept:C0441655 | lld:lifeskim |
pubmed-article:17400462 | lifeskim:mentions | umls-concept:C0204727 | lld:lifeskim |
pubmed-article:17400462 | lifeskim:mentions | umls-concept:C0205409 | lld:lifeskim |
pubmed-article:17400462 | lifeskim:mentions | umls-concept:C0870883 | lld:lifeskim |
pubmed-article:17400462 | lifeskim:mentions | umls-concept:C1533691 | lld:lifeskim |
pubmed-article:17400462 | lifeskim:mentions | umls-concept:C0175668 | lld:lifeskim |
pubmed-article:17400462 | lifeskim:mentions | umls-concept:C1958696 | lld:lifeskim |
pubmed-article:17400462 | pubmed:issue | 11 | lld:pubmed |
pubmed-article:17400462 | pubmed:dateCreated | 2007-4-30 | lld:pubmed |
pubmed-article:17400462 | pubmed:abstractText | Four compounds were isolated from Enicosanthum membranifolium. The structures of the compounds were confirmed by spectroscopic data. Their structures were determined as N-trans-feruloyltyramine, R-(-)-mellein, clerodermic acid, and salicifoline chloride as a quaternary alkaloid compound. The structures of R-(-)-mellein and salicifoline chloride were confirmed by using X-ray diffraction. Clerodermic acid was shown to induce potent apoptosis against human leukemia HL60 cells. | lld:pubmed |
pubmed-article:17400462 | pubmed:language | eng | lld:pubmed |
pubmed-article:17400462 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:17400462 | pubmed:citationSubset | IM | lld:pubmed |
pubmed-article:17400462 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:17400462 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:17400462 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:17400462 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:17400462 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:17400462 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:17400462 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:17400462 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:17400462 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:17400462 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:17400462 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:17400462 | pubmed:status | MEDLINE | lld:pubmed |
pubmed-article:17400462 | pubmed:month | Jun | lld:pubmed |
pubmed-article:17400462 | pubmed:issn | 0968-0896 | lld:pubmed |
pubmed-article:17400462 | pubmed:author | pubmed-author:KoketsuMamoru... | lld:pubmed |
pubmed-article:17400462 | pubmed:author | pubmed-author:IshiharaHideh... | lld:pubmed |
pubmed-article:17400462 | pubmed:author | pubmed-author:AkaoYukihiroY | lld:pubmed |
pubmed-article:17400462 | pubmed:author | pubmed-author:NozawaYoshino... | lld:pubmed |
pubmed-article:17400462 | pubmed:author | pubmed-author:ItohTomohiroT | lld:pubmed |
pubmed-article:17400462 | pubmed:author | pubmed-author:EfdiMaiM | lld:pubmed |
pubmed-article:17400462 | pubmed:issnType | Print | lld:pubmed |
pubmed-article:17400462 | pubmed:day | 1 | lld:pubmed |
pubmed-article:17400462 | pubmed:volume | 15 | lld:pubmed |
pubmed-article:17400462 | pubmed:owner | NLM | lld:pubmed |
pubmed-article:17400462 | pubmed:authorsComplete | Y | lld:pubmed |
pubmed-article:17400462 | pubmed:pagination | 3667-71 | lld:pubmed |
pubmed-article:17400462 | pubmed:meshHeading | pubmed-meshheading:17400462... | lld:pubmed |
pubmed-article:17400462 | pubmed:meshHeading | pubmed-meshheading:17400462... | lld:pubmed |
pubmed-article:17400462 | pubmed:meshHeading | pubmed-meshheading:17400462... | lld:pubmed |
pubmed-article:17400462 | pubmed:meshHeading | pubmed-meshheading:17400462... | lld:pubmed |
pubmed-article:17400462 | pubmed:meshHeading | pubmed-meshheading:17400462... | lld:pubmed |
pubmed-article:17400462 | pubmed:meshHeading | pubmed-meshheading:17400462... | lld:pubmed |
pubmed-article:17400462 | pubmed:meshHeading | pubmed-meshheading:17400462... | lld:pubmed |
pubmed-article:17400462 | pubmed:meshHeading | pubmed-meshheading:17400462... | lld:pubmed |
pubmed-article:17400462 | pubmed:meshHeading | pubmed-meshheading:17400462... | lld:pubmed |
pubmed-article:17400462 | pubmed:meshHeading | pubmed-meshheading:17400462... | lld:pubmed |
pubmed-article:17400462 | pubmed:meshHeading | pubmed-meshheading:17400462... | lld:pubmed |
pubmed-article:17400462 | pubmed:meshHeading | pubmed-meshheading:17400462... | lld:pubmed |
pubmed-article:17400462 | pubmed:year | 2007 | lld:pubmed |
pubmed-article:17400462 | pubmed:articleTitle | The isolation of secondary metabolites and in vitro potent anti-cancer activity of clerodermic acid from Enicosanthum membranifolium. | lld:pubmed |
pubmed-article:17400462 | pubmed:affiliation | Department of Chemistry, Faculty of Engineering, Gifu University, Gifu 501-1193, Japan. | lld:pubmed |
pubmed-article:17400462 | pubmed:publicationType | Journal Article | lld:pubmed |
http://linkedlifedata.com/r... | http://linkedlifedata.com/r... | pubmed-article:17400462 | lld:chembl |